Recursion Pharmaceuticals's market cap is currently $4.16B. The company's EPS TTM is $-1.527; its P/E ratio is ―; Recursion Pharmaceuticals is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 44.58M	$ 39.68M	$ 10.00M	$ 3.41M	$ 1.71M
Gross Profit	$ 1.99M	$ -8.59M	$ 896.00K	$ -59.91M	$ -44.10M
Operating Income	$ -350.06M	$ -245.73M	$ -182.78M	$ -84.61M	$ -62.44M
EBITDA	$ -299.57M	$ -227.66M	$ -174.42M	$ -81.70M	$ -58.34M
Net Income	$ -328.07M	$ -239.42M	$ -178.07M	$ -87.88M	$ -62.52M
Balance Sheet
Cash & Short-Term Investments	$ 391.56M	$ 549.91M	$ 516.56M	$ 262.13M	$ 69.88M
Total Assets	$ 653.70M	$ 701.29M	$ 610.35M	$ 298.58M	$ 101.43M
Total Debt	$ 50.67M	$ 51.01M	$ 11.48M	$ 15.66M	$ 16.17M
Net Debt	$ -340.89M	$ -498.91M	$ -273.64M	$ -246.46M	$ -53.71M
Total Liabilities	$ 190.26M	$ 215.48M	$ 67.41M	$ 504.87M	$ 225.70M
Stockholders' Equity	$ 463.44M	$ 485.81M	$ 542.94M	$ -206.29M	$ -124.27M
Cash Flow
Free Cash Flow	$ -300.33M	$ -120.88M	$ -198.41M	$ -52.13M	$ -60.95M
Operating Cash Flow	$ -287.78M	$ -83.52M	$ -158.61M	$ -45.40M	$ -57.04M
Investing Cash Flow	$ -10.23M	$ 193.25M	$ -271.74M	$ -8.74M	$ -3.91M
Financing Cash Flow	$ 140.13M	$ 154.34M	$ 458.54M	$ 246.13M	$ 120.41M

Currency in USD

Recursion Pharmaceuticals Earnings and Revenue History

Income Statement >

Recursion Pharmaceuticals Debt to Assets

Balance Sheet >

Recursion Pharmaceuticals Cash Flow

Cash Flow >

Recursion Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing